Poland· PL-100458616
Calcium-Sandoz Forte
A calcium (verschiedene salze in kombination) product containing calcii lactogluconas + calcii carbonas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Calcium (verschiedene salze in kombination) is registered in 3 of 19 countries.
Countries holding a registration under ATC A12AA20 (calcium (verschiedene salze in kombination)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Calcium (verschiedene salze in kombination) · ATC A12AA20
3 / 19 countries
- Finlandprice
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Calcii lactogluconas + Calcii carbonas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A12AA20
- ATC class
- Calcium (verschiedene Salze in Kombination)
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991467081
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for calcium (verschiedene salze in kombination).
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Calcium (verschiedene salze in kombination) · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Calcium (verschiedene salze in kombination) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCalcium-SandozNovartis Finland Oy
- NorwayCalcium sandozSandoz A/S
- United KingdomCalvive 1000 effervescent tabletsHaleon UK Trading Ltd
- GermanyCalcium ForteHexal Ag
- IcelandCalcium SandozSandoz A/S
- SpainCALCIUMOSTEO 500 mg COMPRIMIDOS EFERVESCENTESHaleon Spain S.A.
- FranceCALCIUM SANDOZ 500 mg, comprimé effervescentSANDOZ
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Calcium Sandoz
- Cyprus · Calsource
- Germany · Calcium Forte
- Spain · Calciumosteo
- France · Calcium Sandoz
- United Kingdom (Northern Ireland) · Calvive
- Greece · Calciomax M.A
- Hungary · Calcium Sandoz
- Italy · Calcium Sandoz
- Norway · Calcium Sandoz
- Portugal · Forte
- Romania · Calciu Forte Sandoz
- Slovenia · Calcium Calvive
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5f64d44-774d-4910-b8b3-f29bff9e7103 GET /v1/drugs/f5f64d44-774d-4910-b8b3-f29bff9e7103?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki musujące",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909991467081 ¦ OTC ¦ 142103\n20 tabl.",
"substance": "Calcii lactogluconas + Calcii carbonas",
"common_name": "Calcii lactogluconas + Calcii carbonas",
"pl_product_id": "100458616",
"pozwolenie_nr": "377/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-10-12"
}See everything about calcium (verschiedene salze in kombination).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.